ArticleMedical devices (Auckland, N.Z.)2018

Development and usability of a new subcutaneous auto-injector device to administer hydroxyprogesterone caproate to reduce the risk of recurrent preterm birth.

Michael N Travanty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.